Concor® Bioequivalence Study in Chinese Participants (Darmstadt-Nantong)
Clinical trial NCT05930808 · COMPLETED
Trial details
- NCT number
- NCT05930808
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-28
- Primary completion
- 2023-06-18
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.